Restricted accessResearch articleFirst published online 1990-03
Metabolic,Electrocardiographic,and Hemodynamic Responses to Increased Circulating Adrenaline: Effects of Selective and Nonselective Beta Adrenoceptor Blockade
Oliver MF: Metabolic response during impending myocardial infarction. Circulation45:491-500, 1972.
2.
Karlsberg RP , Cryer PE, Roberts R.: Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: Relationship to infarct extent and mortality. Am Heart J102:24-28, 1981.
3.
Opie LH: Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Am J Cardiol36:938-953, 1975.
4.
Struthers AD , Reid JL: The role of adrenal medullary catecholamines in potassium homeostasis. Clin Sci66:377-382, 1984.
5.
Ebel H., Günther T.: Role of magnesium in cardiac disease. J Clin ChemBiochem21:249-265, 1983.
6.
Opie LH: Metabolic response during impending myocardial infarction. Circulation45:483-490, 1972.
7.
Sugiyama S., Miyazaki Y., Kotaka K., et al: Mechanism of free fatty acid-induced arrhythmias. J Electrocardiol15:227-232, 1982.
8.
Dyckner T.: Serum magnesium in acute myocardial infarction. Acta Med Scand207:59-66, 1980.
9.
Kafka H., Langevin L., Armstrong PW: Serum magnesium and potassium in acute myocardial infarction. Arch Intern Med147:465-469, 1987.
10.
Nordrehaug JE, Von Der Lippe G: Hypokalaemia and ventricular fibrillation in acute myocardial infarction. Br Heart J50:525-529, 1983.
11.
Nordrehaug JE, Johannessen KA, Von Der Lippe G: Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction . Circulation71:645-649, 1985.
12.
Nordrehaug JE, Von Der Lippe G: Serum potassium concentrations are inversely related to ventricular, but not to atrial, arrhythmias in acute myocardial infarction. Eur Heart J7:204-209, 1986.
13.
Whyte KF, Addis GJ, Whitesmith R., et al: Adrenergic control of plasma magnesium in man. Clin Sci72:135-138, 1987.
14.
Struthers AD , Reid JL, Whitesmith R., et al: Effect of intravenous adrenaline on electrocardiogram, blood pressure, and serum potassium. Br Heart J49:90-93, 1983.
15.
Johansson BW , Hansen O., Juul-Möller S., et al: Adrenaline-induced changes in serum electrolytes, ECG, and blood pressure, with Ca-blockade pretreatment . Angiology39:345-354, 1988.
16.
Johansson BW : Ventricular repolarization and fibrillation threshold in hibernating species. Eur Heart J6 (Suppl D):53-62, 1985.
17.
Davis SV, Olichwier KK, Chakko SC: Reversible depression of myocardial performance in hypophosphatemia . Am J Med Sci295:183-187, 1988.
18.
Knochel JP: The clinical status of hypophosphatemia. N Engl J Med313:447-449, 1985.
19.
Struthers AD , Whitesmith R., Reid JL: Metabolic and hemodynamic effects of increased circulating adrenaline in man. Br Heart J50:277-281, 1983.
20.
Cleophas Tjm , Stapper GJ: Pressor responses from noncardioselective beta-blockers in mildly hypertensive patients during hospitalization. Abstract, 35th Annual Meeting, Am College of Angiology, 1988.
21.
Struthers AD , Reid JL, Whitesmith R., et al: The effects of cardioselective and nonselective beta-adrenoceptor blockade on the hypokalaemic and cardiovascular responses to adrenomedullary hormones in man. Clin Sci65:143-147, 1983.
22.
Robberecht P., Delhaye M., Taton G., et al: The human heart beta-adrenergic receptors . Mol Pharmacol24:169-173, 1983.
23.
Edvardsson N., Bertil Olsson S: Effects of acute and chronic beta-receptor blockade on ventricular repolarization in man. Br Heart J45:628-636, 1981.
24.
Raptis S., Rosenthal J., Welzel D., et al: Effects of cardioselective and non-cardioselective beta-blockade on adrenaline-induced metabolic and cardiovascular responses in man. Eur J Clin Pharmacol20:17-22, 1981.
25.
William-Olsson T., Fellenius E., Björntorp P., et al: Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration . Acta Med Scand205:201-206, 1979.
26.
Ljunghall S. , Joborn H., Rastad J., et al: Plasma potassium and phosphate concentrations—influence by adrenaline infusion, beta-blockade and physical exercise. Acta Med Scand221:83-93, 1987.
27.
Massara F., Camanni F.: Propranolol block of adrenaline-induced hypophosphataemia in man. Clin Sci38:245-250, 1970.
28.
Body JJ, Cryer PE, Offord KP, et al: Epinephrine is a hypophosphatemic hormone in man. J Clin Invest71:572-578, 1983.
29.
Stoff JS: Phosphate homeostasis and hypophosphatemia. Am J Med72:489-495, 1982.
30.
Smith SR, Kendall MJ: Metabolic responses to beta-2 stimulants. J R Coll PhysiciansLond18:190-194, 1984.
31.
Bos Wjw, Postma DS, van Doormaal JJ: Magnesiuric and calciuric effects of terbutaline in man. Clin Sci74:595-597, 1988.
32.
Bhattacharya SK, Luther RW, Pate JW, et al: Soft tissue calcium and magnesium content in acute pancreatitis in the dog: Calcium accumulation, a mechanism for hypocalcemia in acute pancreatitis. J Lab Clin Med105:422-427, 1985.
33.
Warshaw AL, Lee KH, Napier TW, et al: Depression of serum calcium by increased plasma free fatty acids in the rat: A mechanism for hypocalcemia in acute pancreatitis. Gastroenterology89:814-820, 1985.
34.
Hansen O., Johansson BW: S-Mg does not change inversely to S-FFA in acute stress situations . Abstract, 35th Annual Meeting, Am College of Angiology , 1988.
35.
Elliott DA, Rizack MA: Epinephrine and adrenocorticotropic hormone-stimulated magnesium accumulation in adipocytes and their plasma membranes. J Biol Chem249:3985-3990, 1974.
36.
Brown MJ, Brown DC, Murphy MB: Hypokalemia from beta-2-adrenoceptor stimulation by circulating epinephrine . N Engl J Med309:1414-1419, 1983 .
37.
TurlapatyPDMV, Altura BM: Magnesium deficiency produces spasm of coronary arteries: Relationship to etiology of sudden death ischemic heart disease. Science208:198-200, 1980.
38.
Levine SR, Crowley TJ, Hai HA: Hypomagnesemia and ventricular tachycardia. Chest81:244-247, 1982.
39.
Chadda KD, Lichstein E., Gupta P.: Hypomagnesemia and refractory cardiac arrhythmia in a nondigitalized patient . Am J Cardiol31:98-100, 1973.
40.
Rasmussen HS , McNair P., Norregard P., et al: Intravenous magnesium in acute myocardial infarction. Lanceti:234-236, 1986.
41.
Smith LF, Heagerty AM, Bing RF, et al: Intravenous infusion of magnesium sulphate after myocardial infarction: Effects on arrhythmias and mortality. Int J Cardiol12:175-180, 1986.
42.
Fletcher GF , Hurst JW, Schlant RC: "Polarizing" solution in patients with acute myocardial infarction. Am Heart J75:319-324, 1968.
43.
Rogers WJ, Segall P., McDaniel HG, et al: Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Am J Cardiol43:801-809, 1979.
44.
Papademitriou V.: Diuretics, hypokalemia, and cardiac arrhythmias: A critical analysis. Am Heart J111:1217-1224, 1986.
45.
Paolisso G. , Sgambato S., Passariello N., et al: Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia29:644-647, 1986.
46.
Rowland E., Krikler DM: Potassium supplementation in the treatment of ventricular arrhythmias . Acta Med Scand647 (Suppl):95-100, 1981.
47.
Hohnloser SH , Verrier RL, Lown B., et al: Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ischemic canine heart. Am Heart J112:32-35, 1986.
48.
Garan H., McGovern BA, Canzanello VJ, et al: The effect of potassium ion depletion on postinfarction canine cardiac arrhythmias. Circulation77:696-704, 1988.
49.
Rasmussen HS , Aurup P., Hojberg S., et al: Magnesium and acute myocardial infarction . Arch Intern Med146:872-874, 1986.
50.
Tansey Mjb, Opie LH: Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet2:419-422, 1983.
51.
Yaroslavsky A., Blum M., Peer G., et al: Serum phosphate shift in acute myocardial infarction. Am Heart J104:884-885, 1982.
52.
Speich M., Gelot S., Robinet N., et al: Changes in magnesium, zinc and calcium in men and women after an acute myocardial infarction. Clin Chim Acta168:19-26, 1987.
53.
Johansson BW , Dziamski R.: Malignant arrhythmias in acute myocardial infarction. Drugs28 (suppl 1):77-85, 1984.
54.
Yusuf S., Peto R., Lewis J., et al: Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis27(5):335-371, 1985.
55.
Johansson BW : Myocardial infarction in Malmö 1960-1968. Acta Med Scand191:505-515, 1972.
56.
Gillum RF, Folsom AR, Blackburn H.: Decline in coronary heart disease mortality. Am J Med76:1055-1065, 1984.
